SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Hilltop Holdings Inc. (HTH) trades at a trailing P/E of 13.7, forward P/E of 17.9. Trailing earnings yield is 7.32%, forward earnings yield 5.57%. PEG 0.26 (Peter Lynch undervalued ≤1.0). Graham Number is $47.33.
Criteria proven by this page:
- VALUE (56/100, Partial) — mixed signals — some valuation metrics are favorable while others are stretched.
- PEG Ratio 0.26 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 7.32% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income.
- Analyst consensus target $36.00 (-3.6% downside) — slight downside risk — the market may be ahead of analyst expectations.
Overall SharesGrow Score: 57/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
~
VALUE
56/100
Price-to-Earnings & upside
Proven by this page
✗
HEALTH
33/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — HTH
Valuation Multiples
P/E (TTM)13.7
Forward P/E17.9
PEG Ratio0.26
Forward PEG1.63
P/B Ratio1.04
P/S Ratio1.41
EV/EBITDA8.5
Per Share Data
EPS (TTM)$2.74
Forward EPS (Est.)$2.08
Book Value / Share$36.35
Revenue / Share$26.88
FCF / Share$-0.13
Yields & Fair Value
Earnings Yield7.32%
Forward Earnings Yield5.57%
Dividend Yield1.98%
Graham Number$47.33
SharesGrow IV$49.91 (+33.6%)
Analyst Target$36.00 (-3.6%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2016 |
20.1 |
-0.68 |
1.57 |
1.77 |
0.20% |
| 2017 |
18.6 |
-2.29 |
1.29 |
1.51 |
0.94% |
| 2018 |
13.9 |
-2.37 |
0.87 |
1.22 |
1.58% |
| 2019 |
10.2 |
0.11 |
1.09 |
1.43 |
1.29% |
| 2020 |
5.5 |
0.06 |
1.06 |
1.14 |
1.32% |
| 2021 |
7.6 |
6.95 |
1.12 |
1.53 |
1.37% |
| 2022 |
18.7 |
-0.29 |
1.03 |
1.56 |
2.03% |
| 2023 |
20.9 |
4.20 |
1.08 |
1.52 |
1.82% |
| 2024 |
16.4 |
5.56 |
0.85 |
1.21 |
2.38% |
| 2025 |
12.9 |
0.25 |
0.98 |
1.31 |
2.13% |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$1.48 |
$1.64B |
$145.89M |
8.9% |
| 2017 |
$1.36 |
$1.63B |
$132.54M |
8.1% |
| 2018 |
$1.28 |
$1.39B |
$121.44M |
8.7% |
| 2019 |
$2.44 |
$1.61B |
$225.29M |
14% |
| 2020 |
$5.01 |
$2.16B |
$447.84M |
20.7% |
| 2021 |
$4.61 |
$1.85B |
$374.5M |
20.2% |
| 2022 |
$1.60 |
$1.35B |
$113.13M |
8.4% |
| 2023 |
$1.69 |
$1.5B |
$109.65M |
7.3% |
| 2024 |
$1.74 |
$1.54B |
$113.21M |
7.3% |
| 2025 |
$2.64 |
$1.63B |
$165.59M |
10.2% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$2.09 |
$1.92 – $2.38 |
$1.25B |
$1.24B – $1.26B |
3 |
| 2027 |
$2.31 |
$2.24 – $2.39 |
$1.31B |
$1.3B – $1.32B |
3 |
